Taipan Members Club  
Microcaps
September 2001


Current IssueHotlineMember Services

     

Itıs always a good time to sell!
Lighten up on some profitable positions as we head into the Autumn months

by Brain Hicks

• Optimal Robotics (OPMR:NASDAQ) has gone nuts—pushing to a high of US$47 a share, a new 52-week high. In July, the company announced it sold a record 315 U-Scan systems in the second quarter of this year.

The announcement spurred a massive rally that day—pushing the stock up US$5 a share on volume of 2 million shares.

The breakout to a new 52-week high is very bullish on a technical basis.

But the bullish technical development is a prime opportunity to sell into strength.

Over the years, the stock is up more than 327% in the Taipan portfolio. I recommend selling into the rally and locking in the profit. Sell Optimal Robotics at current levels.

Another FDA Disappointment For Aviron… Another Buying Opportunity For You?

Perhaps.

I’m writing this on August 8, days after the FDA voted 10-4 to not approve Aviron’s FluMist. The non-approval decision was based on safety concerns, not efficacy.

The way I read the advisory team’s explanation is that it doesn’t necessary think FluMist is unsafe. Rather, Aviron didn’t provide enough evidence that FluMist isn’t unsafe.

There’s a big difference.

And that might explain why the stock—after the negative advisory meeting—didn’t sell off that much.

I’ve been in biotechs that have been shot down by the FDA… and the stock lost 50% to 75% in one day.

As I write this, Aviron (AVIR:NASDAQ) is trading at US$29 a share.

Not bad. Not bad at all.

Now, I’ve always made money on Aviron. In fact, I’ve played it on several separate occasions.

But I want to sell it.

Taipan entered Aviron at about US$22 a share. Even after the negative review by the FDA, we’re still up 32%, which is a blessing.

Don’t ask any questions—just sell.

But keep an eye on it. I may re-enter the stock if it pulls back to levels I feel are compelling.

Three times is the charm, right?

I have one more stock I want to sell—Sensormatic (SRM:NYSE).

Taipan entered Sensormatic in October of 1999 at a price of US$12.50. I recommended the stock based on very compelling valuations. In other words, it was cheap as hell.

Well, Tyco International just announced it’s going to acquire Sensormatic for US$24 a share. This is roughly 92% over our entry price.

But I recommend you sell now. Don’t wait for the buyout. Take the money and run.

Sometimes a deal will fall through… and the shareholder is left holding the bag.



© Copyright by Agora Taipan, LLC • 808 Saint Paul Street, Baltimore, MD 21202 USA.
Site Design, Development & Hosting by e.magination network, llc.